Therapeutic benefit of blocking interleukin-6 activity with an anti-interleukin-6 receptor monoclonal antibody in rheumatoid arthritis: a randomized, double-blind, placebo-controlled, dose-escalation trial.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Arthritis & Rheumatism

• Publication date

  2002-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/ART.10623PMID 12483717
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cytokine pathways and joint inflammation in rheumatoid arthritis.

  2001cited by this paper
• A multicenter cross sectional study on bone mineral density in rheumatoid arthritis. Italian Study Group on Bone Mass in Rheumatoid Arthritis.

  2000cited by this paper
• Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group.

  2000cited by this paper
• Etanercept therapy in rheumatoid arthritis. A randomized, controlled trial.

  1999cited by this paper
• Etanercept Therapy in Rheumatoid Arthritis

  1999cited by this paper
• Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist.

  1998cited by this paper
• The Pathophysiologic Roles of Interleukin-6 in Human Disease

  1998cited by this paper
• Management of rheumatoid arthritis.

  1997cited by this paper
• Gp130 and the interleukin-6 family of cytokines.

  1997cited by this paper
• Interleukin‐6 and soluble interleukin‐6 receptors in the synovial fluids from rheumatoid arthritis patients are responsible for osteoclast‐like cell formation

  1996cited by this paper
• American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis.

  1995cited by this paper
• Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis.

  1995cited by this paper
• Long-term outcomes in rheumatoid arthritis.

  1995cited by this paper
• World Health Organization and International League of Associations for Rheumatology core endpoints for symptom modifying antirheumatic drugs in rheumatoid arthritis clinical trials.

  1994cited by this paper
• Treatment of severe rheumatoid arthritis by anti-interleukin 6 monoclonal antibody.

  1993cited by this paper
• Antirheumatic gold compounds and penicillamine enhance protein kinase C‐mediated activation of the arachidonate‐ mobilizing phospholipase A2 in mouse macrophages

  1993cited by this paper
• Interleukin-6 and its receptor in autoimmunity.

  1992cited by this paper
• TNF alpha--a pivotal role in rheumatoid arthritis?

  1992cited by this paper
• IL-6 and soluble IL-2 receptor in rheumatoid arthritis patients treated with second line drugs.

  1992cited by this paper
• Serial estimation of interleukin 6 as a measure of systemic disease in rheumatoid arthritis.

  1992cited by this paper
• Revised criteria for the classification of rheumatoid arthritis.

  1990cited by this paper
• Synovium as a source of interleukin 6 in vitro. Contribution to local and systemic manifestations of arthritis.

  1989cited by this paper
• Interleukin-6 (IL-6) in synovial fluid and serum of patients with rheumatic diseases.

  1988cited by this paper
• The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.

  1988cited by this paper
• Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides.

  1988cited by this paper
• Excessive production of interleukin 6/B cell stimulatory factor‐2 in rheumatoid arthritis

  1988cited by this paper

• Exploring the Links between Rheumatoid Arthritis and Pulpal-Periapical Diseases: Insights from Meta-analysis and Two-Sample Mendelian Randomization.

  2025cites this paper
• Serum biomarkers in rheumatoid arthritis patients and effect of unani herbal formulation Qurs-e-hudar on these biomarkers suggesting the anti-IL-6 effect

  2025cites this paper
• Targeting rheumatoid arthritis: a molecular perspective on biologic therapies and clinical progress

  2025cites this paper
• Understanding inflammatory pathways in cardiovascular diseases: A step toward targeted anti-inflammatory therapies

  2025cites this paper
• When borders impact science: what is the future of European rheumatology research?

  2025cites this paper
• Interleukin-6 as the preferred prognostic factor in infection-complicated acute myeloid leukemia

  2025cites this paper
• Characterization and functional analysis of interleukin-6 and its receptor subunits (IL-6Rα and IL-6Rβ) in the yellow drum, Nibea alibiflora.

  2024cites this paper
• Pathogenic role of anti‐nuclear autoantibodies in systemic sclerosis: Insights from other rheumatic diseases

  2024cites this paper
• Antibodies targeting the shared cytokine receptor IL-1 receptor accessory protein invoke distinct mechanisms to block all cytokine signaling

  2024cites this paper
• Exploring the effect on primary endpoints in trials testing targeted therapy interventions for rheumatoid arthritis: a meta-epidemiological study on the appropriate use of a core outcome set

  2024cites this paper
• Targeting interleukin-6 as a treatment approach for peritoneal carcinomatosis

  2024cites this paper
• Il-6 signaling exacerbates hallmarks of chronic tendon disease by stimulating reparative fibroblasts

  2024cites this paper
• Cyclocurcumin as Promising Bioactive Natural Compound: An Overview

  2024cites this paper
• Fight the Fire: Association of Cytokine Genomic Markers and Suicidal Behavior May Pave the Way for Future Therapies

  2023cites this paper
• Protocol for the Psychosis Immune Mechanism Stratified Medicine (PIMS) trial: a randomised double-blind placebo-controlled trial of single-dose tocilizumab in patients with psychosis

  2023cites this paper
• An insilico analysis to check the effect of novel drug molecules with Interleukin-6 on Rheumatoid arthritis

  2023cites this paper
• Pulsed ultrasound promotes secretion of anti-inflammatory extracellular vesicles from skeletal myotubes via elevation of intracellular calcium level

  2023cites this paper
• Overview of Rheumatoid Arthritis and Scientific Understanding of the Disease

  2023cites this paper
• Association between rheumatoid arthritis and pulpal-periapical pathology: a systematic review

  2023cites this paper
• Liquiritigenin, isoliquiritigenin rich extract of glycyrrhiza glabra roots attenuates inflammation in macrophages and collagen-induced arthritis in rats

  2023cites this paper
• Ultrasound-Targeted Microbubble Destruction-Mediated Cell-Mimetic Nanodrugs for Treating Rheumatoid Arthritis.

  2023cites this paper
• Tocilizumab in Juvenile Idiopathic Arthritis Associated Uveitis, a Narrative Review

  2023cites this paper
• Biologic Therapies in Juvenile Idiopathic Arthritis

  2023cites this paper
• Antinociceptive and anti-inflammatory properties of α-d-mannan from the yeast Kluyveromyces marxianus: evidence for a role in interleukin-6 inhibition

  2023cites this paper
• Major depressive disorder (mdd): emerging immune targets at preclinical level

  2023cites this paper
• Methylprednisolone continuous infusion versus tocilizumab in treatment of hospitalized COVID‑19 patients: Retrospective data analysis and comparison of effects

  2022cites this paper
• IL-6 Revisited: From Rheumatoid Arthritis to CAR T Cell Therapy and COVID-19.

  2022cites this paper
• CLINICAL AND ECONOMIC ANALYSIS OF GENETICALLY ENGINEERED BIOLOGICS CONSUMPTION BY PATIENTS WITH COVID-19

  2022cites this paper
• High Sensitivity C Reactive Protein in Patients with Rheumatoid Arthritis Treated with Antibodies against IL-6 or Jak Inhibitors: A Clinical and Ultrasonographic Study

  2022cites this paper
• Anti-Interleukin 6 Therapeutics for Chronic Antibody-Mediated Rejection In Kidney Transplant Recipients.

  2022cites this paper
• Lessons learned from the preclinical discovery and development of sarilumab for the treatment of rheumatoid arthritis

  2022cites this paper
• RNA-Sequencing Analysis of the Spleen and Gill of Takifugu rubripes in Response to Vibrio harveyi Infection

  2022cites this paper
• Randomized clinical trials on the efficacy and safety of tocilizumab in subjects with rheumatoid arthritis: a systematic review.

  2022cites this paper
• Adverse effects of biologic anti-inflammatory agents on the respiratory system: A review

  2021influential citation
• Pharmacological and Toxicological Study of Coumarinolignoids from Cleome viscosa in Small Animals for the Management of Rheumatoid Arthritis

  2021cites this paper
• Zytokine in der pädiatrischen Rheumatologie

  2021cites this paper
• Drug discovery in rheumatoid arthritis with joint effusion identified by text mining and biomedical databases.

  2021cites this paper
• Periodontitis in Italian patients with established rheumatoid arthritis: a cross-sectional study.

  2021cites this paper
• Modeling and Simulation to Support Phase Ib/IIa Dose Selection for WBP216, A Long Half-Life Fully Human Monoclonal Antibody Against Interleukin-6

  2021cites this paper
• IL-6 family cytokines in respiratory health and disease.

  2021cites this paper
• Decision tree analysis for evaluating disease activity in patients with rheumatoid arthritis

  2021cites this paper
• The role of IL-6 and IL-6 blockade in COVID-19

  2021cites this paper
• The Anti-Inflammatory Actions and Mechanisms of Acupuncture from Acupoint to Target Organs via Neuro-Immune Regulation

  2021cites this paper
• Overactive STAT3 drives accumulation of disease-associated CD21low B cells

  2021cites this paper
• Zytokin-Inhibitoren in der pädiatrischen Rheumatologie

  2021cites this paper
• Biomarker identification and pathway analysis of rheumatoid arthritis based on metabolomics in combination with ingenuity pathway analysis

  2021cites this paper
• Interleucina-6

  2021cites this paper
• How long does it take to translate research findings into routine healthcare practice?—the case of biological drugs for rheumatoid arthritis in Brazil

  2021cites this paper
• Emerging roles for IL-11 in inflammatory diseases.

  2021cites this paper
• PAQR11 modulates monocyte‐to‐macrophage differentiation and pathogenesis of rheumatoid arthritis

  2021cites this paper
• Possible role of β-galactosidase in rheumatoid arthritis

  2020cites this paper
• IL-6 in inflammation, autoimmunity and cancer

  2020cites this paper
• Destructive Roles of Fibroblast-like Synoviocytes in Chronic Inflammation and Joint Damage in Rheumatoid Arthritis

  2020cites this paper
• Traditional and modern management strategies for rheumatoid arthritis.

  2020cites this paper
• The immune regulation of PD-1/PDL-1 axis, a potential biomarker in multiple sclerosis

  2020cites this paper
• Inhibition of Interleukin-6 Signaling Attenuates Aortitis, Left Ventricular Hypertrophy and Arthritis in Interleukin-1 Receptor Antagonist Deficient Mice.

  2020cites this paper
• Molecular docking and molecular dynamics to identify collagenase inhibitors as lead compounds to address osteoarthritis

  2020cites this paper
• Translating IL-6 biology into effective treatments

  2020cites this paper
• CAR T Cell Therapy During the COVID-19 Pandemic.

  2020cites this paper
• Protocol for Systematic Review and Meta-Analysis on the Efficacy and Safety of Tocilizumab

  2020cites this paper
• Immune Cell Paracrine Signaling Drives the Neutrophil Response to A. fumigatus in an Infection-on-a-Chip Model

  2020cites this paper
• Polymorphisms Involved in Response to Biological Agents Used in Rheumatoid Arthritis

  2020cites this paper
• Targeting Aging Pathways in Chronic Obstructive Pulmonary Disease

  2020cites this paper
• Title Regulation of immune responses and chronic inflammation by fibroblast-like synoviocytes

  2020cites this paper
• Cytokine profile in the sputum of subjects with post-tuberculosis airflow obstruction and in those with tobacco related chronic obstructive pulmonary disease

  2020cites this paper
• Inhibitory Effects of Aucklandia lappa Decne. Extract on Inflammatory and Oxidative Responses in LPS-Treated Macrophages

  2020cites this paper
• Effects of Tocilizumab, an Anti-Interleukin-6 Receptor Antibody, on Serum Lipid and Adipokine Levels in Patients with Rheumatoid Arthritis

  2019cites this paper
• Chapter 6 Autoantibodies and Cytokines in Pathogenesis of Rheumatoid Arthritis

  2019cites this paper
• Using the Immunophenotype to Predict Response to Biologic Drugs in Rheumatoid Arthritis

  2019cites this paper
• Inflammation-associated genomic instability in cancer

  2019cites this paper
• Osteoclasts Modulate Bone Erosion in Cholesteatoma via RANKL Signaling

  2019cites this paper
• Targeting Interleukin-6 Signaling in Clinic.

  2019cites this paper
• IL-6 Mediated Transcriptional Programming of Naïve CD4+ T Cells in Early Rheumatoid Arthritis Drives Dysregulated Effector Function

  2019cites this paper
• Regulation of Immune Responses and Chronic Inflammation by Fibroblast-Like Synoviocytes

  2019cites this paper
• Acceleration of nano‐surface and molecular‐orientation limited (nSMOL) proteolysis with acidified reduction pretreatment for quantification of Tocilizumab

  2019cites this paper
• Antiinflammatory Properties of Schinus terebinthifolius and Its Use in Arthritic Conditions

  2019cites this paper
• Decreased H19, GAS5, and linc0597 Expression and Association Analysis of Related Gene Polymorphisms in Rheumatoid Arthritis

  2019cites this paper
• Impact of Exercise on Inflammatory Mediators of Metabolic and Vascular Insulin Resistance in Type 2 Diabetes.

  2019cites this paper
• Tocilizumab (Actemra, RoActemra)

  2019cites this paper
• Tofacitinib for the treatment of rheumatoid arthritis: an update

  2019cites this paper
• Early phase and adaptive design clinical trials in rheumatoid arthritis: a systematic review of early phase trials

  2018cites this paper
• Therapeutic targeting of the IL-6 trans-signalling / mTORC 1 axis in pulmonary emphysema

  2018cites this paper
• The Two-Faced Cytokine IL-6 in Host Defense and Diseases

  2018cites this paper
• Early arthritis induces disturbances at bone nanostructural level reflected in decreased tissue hardness in an animal model of arthritis

  2018cites this paper
• Characterising bidirectional interactions between synovial fibroblasts and myeloid cells

  2018cites this paper
• Chloroquine Protects Human Corneal Epithelial Cells from Desiccation Stress Induced Inflammation without Altering the Autophagy Flux

  2018cites this paper
• Autoantibodies and Cytokines in Pathogenesis of Rheumatoid Arthritis

  2018cites this paper
• Interleukin‐6 gets involved in response to bacterial infection and promotes antibody production in Nile tilapia (Oreochromis niloticus)

  2018cites this paper
• The main goal of this work was to analyze the early arthritis induced events at bone architecture and mechanical properties at tissue level

  2018cites this paper
• Interaction with an endothelial lumen increases neutrophil lifetime and motility in response to P aeruginosa.

  2018cites this paper
• Serum Protein N-Glycosylation Changes with Rheumatoid Arthritis Disease Activity during and after Pregnancy

  2018cites this paper
• The Utility of Anti-Inflammatory Agents in Cardiovascular Disease

  2018cites this paper
• LAIR‐1 shedding from human fibroblast‐like synoviocytes in rheumatoid arthritis following TNF‐α stimulation

  2018cites this paper
• 1,25-Dihydroxyvitamin D3 modulates T cell differentiation and impacts on the production of cytokines from Chinese Han patients with early rheumatoid arthritis

  2018cites this paper
• Interleukin (IL-6) Immunotherapy.

  2018influential citation
• Chapter 63 – Anti-cytokine Therapies

  2017cites this paper
• Cyclocurcumin, a curcumin derivative, exhibits immune-modulating ability and is a potential compound for the treatment of rheumatoid arthritis as predicted by the MM-PBSA method

  2017cites this paper
• A novel scoring system based on common laboratory tests predicts the efficacy of TNF-inhibitor and IL-6 targeted therapy in patients with rheumatoid arthritis: a retrospective, multicenter observational study

  2017cites this paper
• Cytokines in Skeletal Muscle Growth and Decay

  2017cites this paper
• Profile of sarilumab and its potential in the treatment of rheumatoid arthritis

  2017cites this paper